StockData
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31

CNBX Pharmaceuticals Inc.

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$197.79K
P/E (TTM)
–
Dividend yield
–

CNBX Pharmaceuticals Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

CNBX Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.